Occam Places David Mullarkey as CEO at Bluestar
Occam recently recruited David Mullarkey to Bluestar Genomics. He takes the helm of this rapidly evolving and highly innovative cancer detection company based on the scientific research of Stephen Quake of Stanford University. Dave comes to the role after having had great success as CEO of Omniome which was acquired by Pacific Biosciences and as President and COO of Ariosa Diagnostics sold to Roche. In addition to bringing deep content knowledge to Bluestar, he will provide strategic wisdom and operational discipline to the company’s imminent product launch and commercialization.
Recent Placements
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.